| Category: | Medical & Pharma, Pharmaceuticals |
|---|---|
| Organizer: | Informa Connect |
| Exhibition center: | Steigenberger Wiltcher's |
| Comment: | HYBRID EVENT |
Hotels search near to Steigenberger Wiltcher's
Overview interest facts - EU Pharmaceutical Law Forum 2024
EUROPE’S LEADING PHARMACEUTICAL LAW KNOWLEDGE AND NETWORKING HUB FOR THE 32ND YEAR RUNNING.
Cutting-Edge Discussions on EU Pharmaceutical Legislation Revisions, New Theories of Harm & the New Era of Digital Clinical Research Data
Network with Pivotal Players including the EU Commission, European's Medicines Agency (EMA), Trailblazing Competition Authorities, the European Data Protection Supervisor (EDPS), Pioneering In-House Counsel and Key Private Practice.
70+ EXPERTS. 4 KEY FOCUSES. THE #1 PHARMACEUTICAL LAW MEETING HUB.
EXPERIENCE SECOND-TO-NONE NETWORKING OPPORTUNITIES WITH THE BRIGHTEST MINDS IN PHARMACEUTICAL LAW
Be A Part Of The Buzz At The Most Successful And High Profile Annual Gathering Of Legal Professionals! Exchange Views And Discuss Issues Of Pivotal Importance Within The Pharmaceutical Legal Industry
Meet In The Legal Hub of Brussels For 3 Days Of Face-To-Face Networking, Making It Easy To Catch Up With Old Acquaintances And Make New Connections
Recommended events
Find airticket to EU Pharmaceutical Law Forum 2024
Recommended events
News
AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan
A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...
22 January 2024New material improves treatment of complex bone infections
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...
29 November 2023Sepsis - as common as cancer, as deadly as a heart attack
In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.
04 September 2023FDA approves first oral treatment for postpartum depression
Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.
10 August 2023New blood test finds two thirds of cancers
A new multi-cancer early detection blood test could speed up diagnosis.
16 June 2023EU Proposes Drug Manufacturing Overhaul, Faces Pushback
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws
04 May 2023